Correction: Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer

In this article (Clin Cancer Res 2014;20:5265–71), which was published in the October 15, 2014, issue of Clinical Cancer Research (1), funding was omitted from the Grant Support section. It should read as follows: “This study was supported by an ASCO Advanced Clinical Research Award (to L. Pusztai), The Breast Cancer Research Foundation (to L. Pusztai and W.F. Symmans), Bristol-Myers Squibb, Inc., and the Cancer Center Support Grant, P30 CA016672.” The authors regret this error.